Skip to main content
. 2013 Oct 1;31(5):1265–1274. doi: 10.1007/s10637-012-9910-y

Fig. 1.

Fig. 1

Maximum percentage reduction from baseline in target lesion size by patient (N = 12). Although one patient had a maximum percentage change in target tumor size from baseline of −100 %, non-target lesions remained and therefore this was not classified as a complete response. Asterisk stable disease of ≥24 weeks in duration; RECIST Response Evaluation Criteria in Solid Tumors